In skeletal muscles neuronal NO synthase (nNOS, designated also as NOS1) was reported to be restricted to the sarcolemma. With the advent of modern powerful immunocytochemical techniques this commonly accepted view appears to be a delusion and has to be re-evaluated.
In the earlier 90's of the past century, NOS1 in skeletal muscle was originally reported to be localized around the border of some muscle fibers identified as type II (fast) fibers 1 . In the following years, the circumferential NOS1 immunostaining pattern of muscle fibers, albeit without discriminating between fast and slow myofiber types, was reproduced by various groups 2, 3 . Positive NOS1 immunolabeling delineating the myofibers and the absence of sarcoplasmic immunostaining were interpreted by the above-quoted authors as proof for exclusive NOS1 localization in the sarcolemma. Limited by the allowed space, we cited only a few publications supporting this commonly accepted point of view. To the time of those studies, immunohistochemical techniques were not, however, what they are now. Modern advances in immunohistochemistry, such as antigen retrieval 4 and signal amplification 5 , permitted to localize all three NOS isoforms, including NOS1, also in sarcoplasmic compartments 6, 7 . Nevertheless the concept of exclusive sarcolemmal NOS1 localization is entertained in all current textbooks and reviews on myology and dystrophinopathies.
The main drawback of this concept is the fact that nobody has actually demonstrated the NOS immunolabeling of the sarcolemma. Misleading statements of the above-quoted authors about the exclusive sarcolemmal NOS1 expression came up from misapprehension of the resolution limit of the light optic. The sarcolemma, which measures only 5-8 nm wide, is much too small to be seen with the light or fluorescent microscope (whose limit of resolution is 0.2 μm). This inability is a source of confusion to beginning students. Moreover, the microscopical image of the layer of the fluorophore or chromogen deposits delineating muscle fibers after immunostaining varies from 0.5 to 2.0 μm, and this is a few orders of magnitude above the real thickness of the sarcolemma. Therefore, the NOS1 immunostaining of this unidentified layer delineating muscle fibers can account for subsarcolemmally located mitochondria and caveolae as well as for the endomysium, if not for all of them together.
Recently, our attention was attracted by an article of Suzuki et al 8 . Double
immunostaining of NOS1 and laminin performed by these authors showed striking parallels in the expression pattern of both proteins around myofibers. This was regarded by the authors as proof for NOS1 targeting to the sarcolemma. In fact, however, they provided evidence for NOS1 localization in the endomysium but, captured by the commonly accepted philosophy, they were unable to realize it. The endomysium, unlike the sarcolemma, is a visibly (under light microscope) distinct structure, and the glycoprotein laminin is one of the constituents of the endomysium. The endomysium, a layer of connective tissue that ensheaths a muscle fiber, is composed mostly from extracellular matrix produced by fibroblasts sparsely dispersed along the myofibers. Along with laminin, the endomysium contains other extracellular matrix proteins like collagens. This prompted us to reproduce the experiment of Suzuki et al 8 with
NOS1immunostaining of skeletal muscles using for co-immunolabeling another constituent of the endomysium -collagen IV. As anticipated, the immunofluorescent labeling of NOS1 revealed positive immunoreactivity in the endomysium visualized through coimmunolabeling of collagen IV (Fig. 1) . In contrast to Suzuki et al 8 and other groups who used standard indirect immunostaining technique, we applied in our experiment heat-induced antigen retrieval in conjunction with tyramide signal amplification as described elsewhere 9 .
This permitted us to detect NOS1 expression also in the sarcoplasma of some myofibers apparently belonging to type II (fast) fibers 10 . Conflicting conclusions reached by other groups about the absence of NOS1 in the sarcoplasma of myofibers are due to a low detection level in their experimental approaches, whereas misleading statements about the NOS1 expression in the sarcolemma came up from misapprehension of the resolution limit of the light optic. 
